{"date":"2026-05-21","count":21,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-1795-2026-05-21-1926-1lxuhb2","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2026-05-21","time":"19:26:41","subject":"本公司對新加坡子公司Lotus International Pte. Ltd.資金貸與案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：美時（1795），2026-05-21 19:26，「本公司對新加坡子公司Lotus International Pte. Ltd.資金貸與案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2026-05-21-1926-1ky38ax","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2026-05-21","time":"19:26:24","subject":"本公司董事會通過子公司Alvogen Korea向OM PHARMA SA購買韓國藥證案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：美時（1795），2026-05-21 19:26，「本公司董事會通過子公司Alvogen Korea向OM PHARMA SA購買韓國藥證案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2026-05-21-1824-zawn5f","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2026-05-21","time":"18:24:50","subject":"公告更正本公司115年董事選任時持股股數","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2026-05-21 18:24，「公告更正本公司115年董事選任時持股股數」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7878-2026-05-21-1715-1azn7qs","company_id":"7878","company":"藥祇","market":"興櫃","industry":"生技醫療","date":"2026-05-21","time":"17:15:18","subject":"(補充)公告本公司115年股東常會改選董事(含獨立董事)暨董事變動達三分之一","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：藥祇（7878），2026-05-21 17:15，「(補充)公告本公司115年股東常會改選董事(含獨立董事)暨董事變動達三分之一」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1760-2026-05-21-1714-10mka3u","company_id":"1760","company":"寶齡富錦","market":"上市","industry":"生技醫療","date":"2026-05-21","time":"17:14:48","subject":"本公司檸檬酸鐵原料藥上市登記進口案獲中國國家藥監局核准","clause":"第51款","fact_date":"2026-05-21","cite_as":"公開資訊觀測站重大訊息：寶齡富錦（1760），2026-05-21 17:14，「本公司檸檬酸鐵原料藥上市登記進口案獲中國國家藥監局核准」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7878-2026-05-21-1714-lmzgs4","company_id":"7878","company":"藥祇","market":"興櫃","industry":"生技醫療","date":"2026-05-21","time":"17:14:10","subject":"(更正認購比例)公告本公司115年第一次現金增資認股基準日等相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：藥祇（7878），2026-05-21 17:14，「(更正認購比例)公告本公司115年第一次現金增資認股基準日等相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4197-2026-05-21-1645-1k1xv21","company_id":"4197","company":"暐世","market":"興櫃","industry":"生技醫療","date":"2026-05-21","time":"16:45:19","subject":"公告本公司法人董事之代表人變動","clause":"第6款","fact_date":"2026-05-21","cite_as":"公開資訊觀測站重大訊息：暐世（4197），2026-05-21 16:45，「公告本公司法人董事之代表人變動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6576-2026-05-21-1559-15i5ka5","company_id":"6576","company":"逸達","market":"上櫃","industry":"生技醫療","date":"2026-05-21","time":"15:59:32","subject":"本公司115年股東常會通過解除董事競業禁止之限制案","clause":"第21款","fact_date":"2026-05-21","cite_as":"公開資訊觀測站重大訊息：逸達（6576），2026-05-21 15:59，「本公司115年股東常會通過解除董事競業禁止之限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7754-2026-05-21-1558-vvlp3f","company_id":"7754","company":"安基生技","market":"興櫃","industry":"生技醫療","date":"2026-05-21","time":"15:58:40","subject":"公告本公司取得日本「QUINAZOLINE DERIVATIVES USEFULAS SELECTIVE HDAC6 INHIBITORS」發明專利","clause":"第44款","fact_date":"2026-05-21","cite_as":"公開資訊觀測站重大訊息：安基生技（7754），2026-05-21 15:58，「公告本公司取得日本「QUINAZOLINE DERIVATIVES USEFULAS SELECTIVE HDAC6 I」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6576-2026-05-21-1558-15e1v8f","company_id":"6576","company":"逸達","market":"上櫃","industry":"生技醫療","date":"2026-05-21","time":"15:58:09","subject":"本公司115年股東常會重要決議事項","clause":"第18款","fact_date":"2026-05-21","cite_as":"公開資訊觀測站重大訊息：逸達（6576），2026-05-21 15:58，「本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7607-2026-05-21-1540-i3yfgo","company_id":"7607","company":"通用幹細胞*","market":"興櫃","industry":"生技醫療","date":"2026-05-21","time":"15:40:02","subject":"公告本公司114年第二期第一次私募普通股收足股款暨增資基準日","clause":"第44款","fact_date":"2026-05-21","cite_as":"公開資訊觀測站重大訊息：通用幹細胞*（7607），2026-05-21 15:40，「公告本公司114年第二期第一次私募普通股收足股款暨增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7827-2026-05-21-1532-1jb8ii5","company_id":"7827","company":"漢康-KY創","market":"上市","industry":"生技醫療","date":"2026-05-21","time":"15:32:57","subject":"公告本公司115年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢康-KY創（7827），2026-05-21 15:32，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7827-2026-05-21-1530-fgcumt","company_id":"7827","company":"漢康-KY創","market":"上市","industry":"生技醫療","date":"2026-05-21","time":"15:30:06","subject":"公告本公司股票創新板初次第一上市前現金增資發行新股承銷價格","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢康-KY創（7827），2026-05-21 15:30，「公告本公司股票創新板初次第一上市前現金增資發行新股承銷價格」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6676-2026-05-21-1527-1v75xhv","company_id":"6676","company":"祥翊","market":"興櫃","industry":"生技醫療","date":"2026-05-21","time":"15:27:17","subject":"公告本公司114年第一次私募普通股收足股款暨增資基準日","clause":"第44款","fact_date":"2026-05-21","cite_as":"公開資訊觀測站重大訊息：祥翊（6676），2026-05-21 15:27，「公告本公司114年第一次私募普通股收足股款暨增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6785-2026-05-21-1506-1g69yl9","company_id":"6785","company":"昱展新藥","market":"上櫃","industry":"生技醫療","date":"2026-05-21","time":"15:06:34","subject":"公告本公司115年股東常會決議通過解除董事競業禁止之限制案","clause":"第21款","fact_date":"2026-05-21","cite_as":"公開資訊觀測站重大訊息：昱展新藥（6785），2026-05-21 15:06，「公告本公司115年股東常會決議通過解除董事競業禁止之限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6785-2026-05-21-1506-11r4gjr","company_id":"6785","company":"昱展新藥","market":"上櫃","industry":"生技醫療","date":"2026-05-21","time":"15:06:13","subject":"公告本公司第二屆薪資報酬委員會委員任期屆滿","clause":"第6款","fact_date":"2026-05-21","cite_as":"公開資訊觀測站重大訊息：昱展新藥（6785），2026-05-21 15:06，「公告本公司第二屆薪資報酬委員會委員任期屆滿」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6785-2026-05-21-1505-8ysypv","company_id":"6785","company":"昱展新藥","market":"上櫃","industry":"生技醫療","date":"2026-05-21","time":"15:05:51","subject":"公告本公司第三屆審計委員會委員名單","clause":"第6款","fact_date":"2026-05-21","cite_as":"公開資訊觀測站重大訊息：昱展新藥（6785），2026-05-21 15:05，「公告本公司第三屆審計委員會委員名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6785-2026-05-21-1505-1fhgha7","company_id":"6785","company":"昱展新藥","market":"上櫃","industry":"生技醫療","date":"2026-05-21","time":"15:05:26","subject":"公告本公司115年股東常會全面改選第五屆董事當選名單","clause":"第6款","fact_date":"2026-05-21","cite_as":"公開資訊觀測站重大訊息：昱展新藥（6785），2026-05-21 15:05，「公告本公司115年股東常會全面改選第五屆董事當選名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6785-2026-05-21-1503-9769qc","company_id":"6785","company":"昱展新藥","market":"上櫃","industry":"生技醫療","date":"2026-05-21","time":"15:03:34","subject":"公告本公司董事會選任董事長","clause":"第6款","fact_date":"2026-05-21","cite_as":"公開資訊觀測站重大訊息：昱展新藥（6785），2026-05-21 15:03，「公告本公司董事會選任董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6785-2026-05-21-1502-1jb8ii5","company_id":"6785","company":"昱展新藥","market":"上櫃","industry":"生技醫療","date":"2026-05-21","time":"15:02:42","subject":"公告本公司115年股東常會重要決議事項","clause":"第18款","fact_date":"2026-05-21","cite_as":"公開資訊觀測站重大訊息：昱展新藥（6785），2026-05-21 15:02，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4194-2026-05-21-1048-fafuio","company_id":"4194","company":"禾生技","market":"興櫃","industry":"生技醫療","date":"2026-05-21","time":"10:48:15","subject":"更新-本公司董事任期屆滿全面改選","clause":"第6款","fact_date":"2026-05-20","cite_as":"公開資訊觀測站重大訊息：禾生技（4194），2026-05-21 10:48，「更新-本公司董事任期屆滿全面改選」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}